These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2014-005384-33 Open-Label, Non-randomized Phase 2 study with Safety Run-in Evaluating Efficacy and Safety of PQR309 in Patients with Relapsed or Refractory Lymphoma bad-data
Reported results 2015-001306-33 Open-label, non-randomized, phase 2 study evaluating efficacy and safety of PQR309 in patients with relapsed or refractory primary CNS lymphoma 2018-03-29 due-trials
Exempt, with results 2015-004225-14 An open label, non-randomized, multicenter phase 1/2b study investigating safety and efficacy of PQR309 and eribulin combination in patients with locally advanced or metastatic HER2 negative and tripl... 2018-10-03 not-yet-due
Reported results Terminated 2016-000125-38 Open-label, Non-randomized Phase 2 Study With Safety Run-in Evaluating Efficacy and Safety of PQR309 in Patients with Relapsed or Refractory Lymphoma 2020-12-01 due-trials
Reported results 2019-001189-14 Exploratory study of the efficacy and safety of topical bimiralisib in an inflammatory and hyperproliferative skin condition 2020-03-16 due-trials